A PYMNTS Company

EU: Dow and DuPont seek to address Brussels’ antitrust concerns

By  |  February 5, 2017

Dow Chemical and DuPont are on the verge of offering to sell research and development capability in response to Brussels’ antitrust concerns over the companies’ planned $140bn merger. The case, which will decide on Tuesday whether to approve the deal, has become a test of European competition regulators’ approach to industrial innovation.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The investigation is the first of three agrichemical megadeals, together worth nearly $250bn, that Margrethe Vestager, EU competition commissioner, will examine this year. Dow and DuPont are seeking to stop the merger being blocked, amid concerns from politicians and consumer groups.

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Brussels’ objections to the deal have attracted particular scrutiny, because it marks the first time the commission has threatened to block a deal primarily based on concerns that it could cut innovation in a whole market. Previous antitrust cases have cited a narrower range of risks to product development in specific markets.

    Full Content: Financial Times

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.